> top > docs > PubMed:20859899 > annotations
TextAE configuration unavailable!

PubMed:20859899 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCoin-entities-OrganismTaxon-PD

Id Subject Object Predicate Lexical cue db_id
T1 0-7 OrganismTaxon denotes Syncope NCBItxid:1271638
T2 143-152 OrganismTaxon denotes old woman NCBItxid:333954

LitCoin-sentences

Id Subject Object Predicate Lexical cue
T1 0-132 Sentence denotes Syncope caused by hyperkalemia during use of a combined therapy with the angiotensin-converting enzyme inhibitor and spironolactone.
T2 133-349 Sentence denotes A 76 year-old woman with a history of coronary artery bypass grafting and prior myocardial infarction was transferred to the emergency room with loss of consciousness due to marked bradycardia caused by hyperkalemia.
T3 350-480 Sentence denotes The concentration of serum potassium was high, and normal sinus rhythm was restored after correction of the serum potassium level.
T4 481-654 Sentence denotes The cause of hyperkalemia was considered to be several doses of spiranolactone, an aldosterone antagonist, in addition to the long-term intake of ramipril, an ACE inhibitor.
T5 655-754 Sentence denotes This case is a good example of electrolyte imbalance causing acute life-threatening cardiac events.
T6 755-944 Sentence denotes Clinicians should be alert to the possibility of hyperkalemia, especially in elderly patients using ACE/ARB in combination with potassium sparing agents and who have mild renal disturbance.

LitCoin-entities

Id Subject Object Predicate Lexical cue db_id
8126 0-7 DiseaseOrPhenotypicFeature denotes Syncope MESH:D013575
8127 18-30 DiseaseOrPhenotypicFeature denotes hyperkalemia MESH:D006947
8128 73-112 ChemicalEntity denotes angiotensin-converting enzyme inhibitor MESH:D000806
8129 117-131 ChemicalEntity denotes spironolactone MESH:D013148
8130 147-152 OrganismTaxon denotes woman NCBITaxon:9606
8131 213-234 DiseaseOrPhenotypicFeature denotes myocardial infarction MESH:D009203
8132 278-299 DiseaseOrPhenotypicFeature denotes loss of consciousness MESH:D014474
8133 314-325 DiseaseOrPhenotypicFeature denotes bradycardia MESH:D001919
8134 336-348 DiseaseOrPhenotypicFeature denotes hyperkalemia MESH:D006947
8135 377-386 ChemicalEntity denotes potassium MESH:D011188
8136 464-473 ChemicalEntity denotes potassium MESH:D011188
8137 494-506 DiseaseOrPhenotypicFeature denotes hyperkalemia MESH:D006947
8138 545-559 ChemicalEntity denotes spiranolactone MESH:D013148
8139 564-575 ChemicalEntity denotes aldosterone MESH:D000450
8140 627-635 ChemicalEntity denotes ramipril MESH:D017257
8141 640-643 GeneOrGeneProduct denotes ACE NCBIGene:1636
8142 804-816 DiseaseOrPhenotypicFeature denotes hyperkalemia MESH:D006947
8143 840-848 OrganismTaxon denotes patients NCBITaxon:9606
8144 855-858 GeneOrGeneProduct denotes ACE NCBIGene:1636
8145 859-862 ChemicalEntity denotes ARB MESH:D057911
8146 883-892 ChemicalEntity denotes potassium MESH:D011188
8147 926-943 DiseaseOrPhenotypicFeature denotes renal disturbance MESH:D007674

LitCoin_Mondo

Id Subject Object Predicate Lexical cue mondo_id
T1 213-234 DiseaseOrPhenotypicFeature denotes myocardial infarction 0005068
T2 408-413 DiseaseOrPhenotypicFeature denotes sinus 0005961

LitCoin-GeneOrGeneProduct-v0

Id Subject Object Predicate Lexical cue
T8 576-586 GeneOrGeneProduct denotes antagonist
T9 607-611 GeneOrGeneProduct denotes long
T10 612-616 GeneOrGeneProduct denotes term
T11 640-643 GeneOrGeneProduct denotes ACE
T12 644-653 GeneOrGeneProduct denotes inhibitor
T13 660-664 GeneOrGeneProduct denotes case
T14 855-858 GeneOrGeneProduct denotes ACE
T1 73-102 GeneOrGeneProduct denotes angiotensin-converting enzyme
T2 103-112 GeneOrGeneProduct denotes inhibitor
T3 138-142 GeneOrGeneProduct denotes year
T4 187-193 GeneOrGeneProduct denotes bypass
T5 307-313 GeneOrGeneProduct denotes marked
T6 391-395 GeneOrGeneProduct denotes high
T7 464-479 GeneOrGeneProduct denotes potassium level

LitCoin-GeneOrGeneProduct-v2

Id Subject Object Predicate Lexical cue
T1 73-102 GeneOrGeneProduct denotes angiotensin-converting enzyme
T2 103-112 GeneOrGeneProduct denotes inhibitor
T3 187-193 GeneOrGeneProduct denotes bypass
T4 391-395 GeneOrGeneProduct denotes high
T5 464-479 GeneOrGeneProduct denotes potassium level
T6 612-616 GeneOrGeneProduct denotes term
T7 644-653 GeneOrGeneProduct denotes inhibitor

LitCoin-Disease-MeSH

Id Subject Object Predicate Lexical cue originalLabel
T1 0-7 DiseaseOrPhenotypicFeature denotes Syncope D013575
T2 18-30 DiseaseOrPhenotypicFeature denotes hyperkalemia D006947
T3 213-234 DiseaseOrPhenotypicFeature denotes myocardial infarction D009203
T4 258-267 DiseaseOrPhenotypicFeature denotes emergency D004630
T5 278-299 DiseaseOrPhenotypicFeature denotes loss of consciousness D014474
T6 314-325 DiseaseOrPhenotypicFeature denotes bradycardia D001919
T7 336-348 DiseaseOrPhenotypicFeature denotes hyperkalemia D006947
T8 408-413 DiseaseOrPhenotypicFeature denotes sinus D012852
T9 494-506 DiseaseOrPhenotypicFeature denotes hyperkalemia D006947
T10 564-575 DiseaseOrPhenotypicFeature denotes aldosterone D006929
T11 804-816 DiseaseOrPhenotypicFeature denotes hyperkalemia D006947

LitCoin_Mondo_095

Id Subject Object Predicate Lexical cue mondo_id
T1 213-234 DiseaseOrPhenotypicFeature denotes myocardial infarction 0005068
T2 859-862 DiseaseOrPhenotypicFeature denotes ARB 0012733

LitCoin-NCBITaxon-2

Id Subject Object Predicate Lexical cue
T1 143-152 OrganismTaxon denotes old woman
T2 840-848 OrganismTaxon denotes patients

LitCoin-MeSH-Disease-2

Id Subject Object Predicate Lexical cue ID:
T1 0-7 DiseaseOrPhenotypicFeature denotes Syncope D013575
T2 18-30 DiseaseOrPhenotypicFeature denotes hyperkalemia D006947
T3 213-234 DiseaseOrPhenotypicFeature denotes myocardial infarction D009203
T4 258-267 DiseaseOrPhenotypicFeature denotes emergency D004630
T5 278-299 DiseaseOrPhenotypicFeature denotes loss of consciousness D014474
T6 314-325 DiseaseOrPhenotypicFeature denotes bradycardia D001919
T7 336-348 DiseaseOrPhenotypicFeature denotes hyperkalemia D006947
T8 494-506 DiseaseOrPhenotypicFeature denotes hyperkalemia D006947
T9 804-816 DiseaseOrPhenotypicFeature denotes hyperkalemia D006947
T10 926-943 DiseaseOrPhenotypicFeature denotes renal disturbance DISEASE

LitCoin-MONDO_bioort2019

Id Subject Object Predicate Lexical cue #label
T1 0-7 DiseaseOrPhenotypicFeature denotes Syncope D013575
T2 18-30 DiseaseOrPhenotypicFeature denotes hyperkalemia D006947
T3 213-234 DiseaseOrPhenotypicFeature denotes myocardial infarction D009203
T4 278-299 DiseaseOrPhenotypicFeature denotes loss of consciousness D014474
T5 314-325 DiseaseOrPhenotypicFeature denotes bradycardia D001919
T6 336-348 DiseaseOrPhenotypicFeature denotes hyperkalemia D006947
T7 494-506 DiseaseOrPhenotypicFeature denotes hyperkalemia D006947
T8 804-816 DiseaseOrPhenotypicFeature denotes hyperkalemia D006947
T9 926-943 DiseaseOrPhenotypicFeature denotes renal disturbance DISEASE

LitCoin-Chemical-MeSH-CHEBI

Id Subject Object Predicate Lexical cue ID:
T1 73-112 ChemicalEntity denotes angiotensin-converting enzyme inhibitor ChemicalEntity
T2 117-131 ChemicalEntity denotes spironolactone D013148|http://purl.obolibrary.org/obo/CHEBI_9241
T4 377-386 ChemicalEntity denotes potassium D011188|http://purl.obolibrary.org/obo/CHEBI_26216
T6 464-473 ChemicalEntity denotes potassium D011188|http://purl.obolibrary.org/obo/CHEBI_26216
T8 545-559 ChemicalEntity denotes spiranolactone ChemicalEntity
T9 564-575 ChemicalEntity denotes aldosterone D000450|http://purl.obolibrary.org/obo/CHEBI_30834|http://purl.obolibrary.org/obo/CHEBI_27584
T12 627-635 ChemicalEntity denotes ramipril D017257|http://purl.obolibrary.org/obo/CHEBI_8774
T14 686-697 ChemicalEntity denotes electrolyte D004573
T15 859-862 ChemicalEntity denotes ARB ChemicalEntity
T16 883-892 ChemicalEntity denotes potassium D011188|http://purl.obolibrary.org/obo/CHEBI_26216

LitCoin-training-merged

Id Subject Object Predicate Lexical cue #label ID:
T16 883-892 ChemicalEntity denotes potassium http://purl.obolibrary.org/obo/CHEBI_26216|D011188
T15 859-862 ChemicalEntity denotes ARB ChemicalEntity
T14 686-697 ChemicalEntity denotes electrolyte D004573
T12 627-635 ChemicalEntity denotes ramipril http://purl.obolibrary.org/obo/CHEBI_8774|D017257
T9 564-575 ChemicalEntity denotes aldosterone http://purl.obolibrary.org/obo/CHEBI_27584|http://purl.obolibrary.org/obo/CHEBI_30834|D000450
T8 545-559 ChemicalEntity denotes spiranolactone ChemicalEntity
T6 464-473 ChemicalEntity denotes potassium http://purl.obolibrary.org/obo/CHEBI_26216|D011188
T4 377-386 ChemicalEntity denotes potassium http://purl.obolibrary.org/obo/CHEBI_26216|D011188
T2 117-131 ChemicalEntity denotes spironolactone http://purl.obolibrary.org/obo/CHEBI_9241|D013148
T1 73-112 ChemicalEntity denotes angiotensin-converting enzyme inhibitor ChemicalEntity
T59427 926-943 DiseaseOrPhenotypicFeature denotes renal disturbance DISEASE
T69308 804-816 DiseaseOrPhenotypicFeature denotes hyperkalemia D006947
T7 494-506 DiseaseOrPhenotypicFeature denotes hyperkalemia D006947
T16111 336-348 DiseaseOrPhenotypicFeature denotes hyperkalemia D006947
T5 314-325 DiseaseOrPhenotypicFeature denotes bradycardia D001919
T90804 278-299 DiseaseOrPhenotypicFeature denotes loss of consciousness D014474
T3 213-234 DiseaseOrPhenotypicFeature denotes myocardial infarction D009203
T99252 18-30 DiseaseOrPhenotypicFeature denotes hyperkalemia D006947
T13924 0-7 DiseaseOrPhenotypicFeature denotes Syncope D013575
T97862 840-848 OrganismTaxon denotes patients
T15648 143-152 OrganismTaxon denotes old woman

PubmedHPO

Id Subject Object Predicate Lexical cue
T1 213-234 HP_0001658 denotes myocardial infarction
T2 278-299 HP_0007185 denotes loss of consciousness
T3 314-325 HP_0001662 denotes bradycardia
T4 336-348 HP_0002153 denotes hyperkalemia
T5 494-506 HP_0002153 denotes hyperkalemia
T6 804-816 HP_0002153 denotes hyperkalemia

PubCasesHPO

Id Subject Object Predicate Lexical cue
TI1 0-7 HP:0001279 denotes Syncope
TI2 18-30 HP:0002153 denotes hyperkalemia
AB1 213-234 HP:0001658 denotes myocardial infarction
AB2 278-299 HP:0007185 denotes loss of consciousness
AB3 314-325 HP:0001662 denotes bradycardia
AB4 336-348 HP:0002153 denotes hyperkalemia
AB5 494-506 HP:0002153 denotes hyperkalemia
AB6 804-816 HP:0002153 denotes hyperkalemia

biored-valid-deepseek-nr-ng

Id Subject Object Predicate Lexical cue
T1 0-7 DiseaseOrPhenotypicFeature denotes Syncope
T2 18-30 DiseaseOrPhenotypicFeature denotes hyperkalemia
T3 73-102 ChemicalEntity denotes angiotensin-converting enzyme
T4 117-131 ChemicalEntity denotes spironolactone
T5 171-202 DiseaseOrPhenotypicFeature denotes coronary artery bypass grafting
T6 207-234 DiseaseOrPhenotypicFeature denotes prior myocardial infarction
T7 336-348 DiseaseOrPhenotypicFeature denotes hyperkalemia
T8 371-386 ChemicalEntity denotes serum potassium
T9 494-506 DiseaseOrPhenotypicFeature denotes hyperkalemia
T10 545-559 ChemicalEntity denotes spiranolactone
T11 564-586 ChemicalEntity denotes aldosterone antagonist
T12 627-635 ChemicalEntity denotes ramipril
T13 640-653 ChemicalEntity denotes ACE inhibitor
T14 686-707 DiseaseOrPhenotypicFeature denotes electrolyte imbalance
T15 855-862 ChemicalEntity denotes ACE/ARB
T16 883-907 ChemicalEntity denotes potassium sparing agents
T17 921-943 DiseaseOrPhenotypicFeature denotes mild renal disturbance

biored-valid-deepseek-nr-g

Id Subject Object Predicate Lexical cue
T1 0-7 DiseaseOrPhenotypicFeature denotes Syncope
T2 18-30 DiseaseOrPhenotypicFeature denotes hyperkalemia
T3 73-102 GeneOrGeneProduct denotes angiotensin-converting enzyme
T4 117-131 ChemicalEntity denotes spironolactone
T5 171-202 DiseaseOrPhenotypicFeature denotes coronary artery bypass grafting
T6 207-234 DiseaseOrPhenotypicFeature denotes prior myocardial infarction
T7 278-299 DiseaseOrPhenotypicFeature denotes loss of consciousness
T8 307-325 DiseaseOrPhenotypicFeature denotes marked bradycardia
T9 336-348 DiseaseOrPhenotypicFeature denotes hyperkalemia
T10 494-506 DiseaseOrPhenotypicFeature denotes hyperkalemia
T11 545-559 ChemicalEntity denotes spiranolactone
T12 564-586 ChemicalEntity denotes aldosterone antagonist
T13 627-635 ChemicalEntity denotes ramipril
T14 640-653 ChemicalEntity denotes ACE inhibitor
T15 686-707 DiseaseOrPhenotypicFeature denotes electrolyte imbalance
T16 716-753 DiseaseOrPhenotypicFeature denotes acute life-threatening cardiac events
T17 859-862 ChemicalEntity denotes ARB
T18 883-907 ChemicalEntity denotes potassium sparing agents
T19 921-943 DiseaseOrPhenotypicFeature denotes mild renal disturbance

biored-valid

Id Subject Object Predicate Lexical cue
T1 0-7 DiseaseOrPhenotypicFeature denotes Syncope
T2 18-30 DiseaseOrPhenotypicFeature denotes hyperkalemia
T3 73-112 ChemicalEntity denotes angiotensin-converting enzyme inhibitor
T4 117-131 ChemicalEntity denotes spironolactone
T5 147-152 OrganismTaxon denotes woman
T6 213-234 DiseaseOrPhenotypicFeature denotes myocardial infarction
T7 278-299 DiseaseOrPhenotypicFeature denotes loss of consciousness
T8 314-325 DiseaseOrPhenotypicFeature denotes bradycardia
T9 336-348 DiseaseOrPhenotypicFeature denotes hyperkalemia
T10 377-386 ChemicalEntity denotes potassium
T11 464-473 ChemicalEntity denotes potassium
T12 494-506 DiseaseOrPhenotypicFeature denotes hyperkalemia
T13 545-559 ChemicalEntity denotes spiranolactone
T14 564-575 ChemicalEntity denotes aldosterone
T15 627-635 ChemicalEntity denotes ramipril
T16 640-643 GeneOrGeneProduct denotes ACE
T17 804-816 DiseaseOrPhenotypicFeature denotes hyperkalemia
T18 840-848 OrganismTaxon denotes patients
T19 855-858 GeneOrGeneProduct denotes ACE
T20 859-862 ChemicalEntity denotes ARB
T21 883-892 ChemicalEntity denotes potassium
T22 926-943 DiseaseOrPhenotypicFeature denotes renal disturbance

biored-valid-deepseek-r-ng

Id Subject Object Predicate Lexical cue
T1 0-7 DiseaseOrPhenotypicFeature denotes Syncope
T2 18-30 DiseaseOrPhenotypicFeature denotes hyperkalemia
T3 73-112 ChemicalEntity denotes angiotensin-converting enzyme inhibitor
T4 117-131 ChemicalEntity denotes spironolactone
T5 213-234 DiseaseOrPhenotypicFeature denotes myocardial infarction
T6 314-325 DiseaseOrPhenotypicFeature denotes bradycardia
T7 336-348 DiseaseOrPhenotypicFeature denotes hyperkalemia
T8 371-386 ChemicalEntity denotes serum potassium
T9 494-506 DiseaseOrPhenotypicFeature denotes hyperkalemia
T10 545-559 ChemicalEntity denotes spiranolactone
T11 564-586 ChemicalEntity denotes aldosterone antagonist
T12 627-635 ChemicalEntity denotes ramipril
T13 640-653 ChemicalEntity denotes ACE inhibitor
T14 686-707 DiseaseOrPhenotypicFeature denotes electrolyte imbalance
T15 739-753 DiseaseOrPhenotypicFeature denotes cardiac events
T16 855-862 ChemicalEntity denotes ACE/ARB
T17 883-907 ChemicalEntity denotes potassium sparing agents
T18 926-943 DiseaseOrPhenotypicFeature denotes renal disturbance

biored-valid-deepseek-r-g

Id Subject Object Predicate Lexical cue
T1 0-7 DiseaseOrPhenotypicFeature denotes Syncope
T2 18-30 DiseaseOrPhenotypicFeature denotes hyperkalemia
T3 73-112 ChemicalEntity denotes angiotensin-converting enzyme inhibitor
T4 117-131 ChemicalEntity denotes spironolactone
T5 213-234 DiseaseOrPhenotypicFeature denotes myocardial infarction
T6 278-299 DiseaseOrPhenotypicFeature denotes loss of consciousness
T7 314-325 DiseaseOrPhenotypicFeature denotes bradycardia
T8 336-348 DiseaseOrPhenotypicFeature denotes hyperkalemia
T9 377-386 ChemicalEntity denotes potassium
T10 494-506 DiseaseOrPhenotypicFeature denotes hyperkalemia
T11 545-559 ChemicalEntity denotes spiranolactone
T12 564-586 ChemicalEntity denotes aldosterone antagonist
T13 627-635 ChemicalEntity denotes ramipril
T14 640-653 ChemicalEntity denotes ACE inhibitor
T15 686-707 DiseaseOrPhenotypicFeature denotes electrolyte imbalance
T16 855-862 ChemicalEntity denotes ACE/ARB
T17 883-907 ChemicalEntity denotes potassium sparing agents
T18 921-943 DiseaseOrPhenotypicFeature denotes mild renal disturbance

biored-valid-gemini-nr-ng

Id Subject Object Predicate Lexical cue
T1 0-7 DiseaseOrPhenotypicFeature denotes Syncope
T2 18-30 DiseaseOrPhenotypicFeature denotes hyperkalemia
T3 73-112 ChemicalEntity denotes angiotensin-converting enzyme inhibitor
T4 117-131 ChemicalEntity denotes spironolactone
T5 171-202 DiseaseOrPhenotypicFeature denotes coronary artery bypass grafting
T6 207-234 DiseaseOrPhenotypicFeature denotes prior myocardial infarction
T7 278-299 DiseaseOrPhenotypicFeature denotes loss of consciousness
T8 307-325 DiseaseOrPhenotypicFeature denotes marked bradycardia
T9 336-348 DiseaseOrPhenotypicFeature denotes hyperkalemia
T10 371-386 ChemicalEntity denotes serum potassium
T11 401-420 DiseaseOrPhenotypicFeature denotes normal sinus rhythm
T12 458-473 ChemicalEntity denotes serum potassium
T13 494-506 DiseaseOrPhenotypicFeature denotes hyperkalemia
T14 545-559 ChemicalEntity denotes spiranolactone
T15 564-586 ChemicalEntity denotes aldosterone antagonist
T16 627-635 ChemicalEntity denotes ramipril
T17 640-653 ChemicalEntity denotes ACE inhibitor
T18 686-707 DiseaseOrPhenotypicFeature denotes electrolyte imbalance
T19 716-753 DiseaseOrPhenotypicFeature denotes acute life-threatening cardiac events
T20 804-816 DiseaseOrPhenotypicFeature denotes hyperkalemia
T21 855-858 GeneOrGeneProduct denotes ACE
T22 859-862 ChemicalEntity denotes ARB
T23 883-907 ChemicalEntity denotes potassium sparing agents
T24 921-943 DiseaseOrPhenotypicFeature denotes mild renal disturbance

biored-valid-gemini-r-g

Id Subject Object Predicate Lexical cue
T1 0-7 DiseaseOrPhenotypicFeature denotes Syncope
T2 18-30 DiseaseOrPhenotypicFeature denotes hyperkalemia
T3 73-112 ChemicalEntity denotes angiotensin-converting enzyme inhibitor
T4 117-131 ChemicalEntity denotes spironolactone
T5 213-234 DiseaseOrPhenotypicFeature denotes myocardial infarction
T6 278-299 DiseaseOrPhenotypicFeature denotes loss of consciousness
T7 314-325 DiseaseOrPhenotypicFeature denotes bradycardia
T8 336-348 DiseaseOrPhenotypicFeature denotes hyperkalemia
T9 377-386 ChemicalEntity denotes potassium
T10 494-506 DiseaseOrPhenotypicFeature denotes hyperkalemia
T11 545-559 ChemicalEntity denotes spiranolactone
T12 564-586 ChemicalEntity denotes aldosterone antagonist
T13 627-635 ChemicalEntity denotes ramipril
T14 640-653 ChemicalEntity denotes ACE inhibitor
T15 686-707 DiseaseOrPhenotypicFeature denotes electrolyte imbalance
T16 804-816 DiseaseOrPhenotypicFeature denotes hyperkalemia
T17 855-862 ChemicalEntity denotes ACE/ARB
T18 883-907 ChemicalEntity denotes potassium sparing agents
T19 926-943 DiseaseOrPhenotypicFeature denotes renal disturbance

biored-valid-gemini-r-ng

Id Subject Object Predicate Lexical cue
T1 0-7 DiseaseOrPhenotypicFeature denotes Syncope
T2 18-30 DiseaseOrPhenotypicFeature denotes hyperkalemia
T3 73-112 ChemicalEntity denotes angiotensin-converting enzyme inhibitor
T4 117-131 ChemicalEntity denotes spironolactone
T5 147-152 OrganismTaxon denotes woman
T6 171-202 DiseaseOrPhenotypicFeature denotes coronary artery bypass grafting
T7 213-234 DiseaseOrPhenotypicFeature denotes myocardial infarction
T8 278-299 DiseaseOrPhenotypicFeature denotes loss of consciousness
T9 307-325 DiseaseOrPhenotypicFeature denotes marked bradycardia
T10 336-348 DiseaseOrPhenotypicFeature denotes hyperkalemia
T11 371-386 ChemicalEntity denotes serum potassium
T12 401-420 DiseaseOrPhenotypicFeature denotes normal sinus rhythm
T13 458-473 ChemicalEntity denotes serum potassium
T14 494-506 DiseaseOrPhenotypicFeature denotes hyperkalemia
T15 545-559 ChemicalEntity denotes spiranolactone
T16 564-586 ChemicalEntity denotes aldosterone antagonist
T17 627-635 ChemicalEntity denotes ramipril
T18 640-653 ChemicalEntity denotes ACE inhibitor
T19 686-707 DiseaseOrPhenotypicFeature denotes electrolyte imbalance
T20 716-753 DiseaseOrPhenotypicFeature denotes acute life-threatening cardiac events
T21 804-816 DiseaseOrPhenotypicFeature denotes hyperkalemia
T22 840-848 OrganismTaxon denotes patients
T23 855-858 GeneOrGeneProduct denotes ACE
T24 859-862 ChemicalEntity denotes ARB
T25 883-907 ChemicalEntity denotes potassium sparing agents
T26 926-943 DiseaseOrPhenotypicFeature denotes renal disturbance

biored-valid-gpt-nr-ng

Id Subject Object Predicate Lexical cue
T1 0-7 DiseaseOrPhenotypicFeature denotes Syncope
T2 18-30 DiseaseOrPhenotypicFeature denotes hyperkalemia
T3 73-112 ChemicalEntity denotes angiotensin-converting enzyme inhibitor
T4 117-131 ChemicalEntity denotes spironolactone
T5 213-234 DiseaseOrPhenotypicFeature denotes myocardial infarction
T6 278-299 DiseaseOrPhenotypicFeature denotes loss of consciousness
T7 314-325 DiseaseOrPhenotypicFeature denotes bradycardia
T8 336-348 DiseaseOrPhenotypicFeature denotes hyperkalemia
T9 377-386 ChemicalEntity denotes potassium
T10 464-473 ChemicalEntity denotes potassium
T11 494-506 DiseaseOrPhenotypicFeature denotes hyperkalemia
T12 545-559 ChemicalEntity denotes spiranolactone
T13 564-586 ChemicalEntity denotes aldosterone antagonist
T14 627-635 ChemicalEntity denotes ramipril
T15 640-653 ChemicalEntity denotes ACE inhibitor
T16 686-707 DiseaseOrPhenotypicFeature denotes electrolyte imbalance
T17 716-753 DiseaseOrPhenotypicFeature denotes acute life-threatening cardiac events
T18 804-816 DiseaseOrPhenotypicFeature denotes hyperkalemia
T19 855-862 ChemicalEntity denotes ACE/ARB
T20 883-907 ChemicalEntity denotes potassium sparing agents
T21 926-943 DiseaseOrPhenotypicFeature denotes renal disturbance

biored-valid-gpt-nr-g

Id Subject Object Predicate Lexical cue
T1 0-7 DiseaseOrPhenotypicFeature denotes Syncope
T2 18-30 DiseaseOrPhenotypicFeature denotes hyperkalemia
T3 73-112 ChemicalEntity denotes angiotensin-converting enzyme inhibitor
T4 117-131 ChemicalEntity denotes spironolactone
T5 213-234 DiseaseOrPhenotypicFeature denotes myocardial infarction
T6 278-299 DiseaseOrPhenotypicFeature denotes loss of consciousness
T7 314-325 DiseaseOrPhenotypicFeature denotes bradycardia
T8 336-348 DiseaseOrPhenotypicFeature denotes hyperkalemia
T9 377-386 ChemicalEntity denotes potassium
T10 464-473 ChemicalEntity denotes potassium
T11 545-559 ChemicalEntity denotes spiranolactone
T12 564-586 ChemicalEntity denotes aldosterone antagonist
T13 627-635 ChemicalEntity denotes ramipril
T14 640-653 ChemicalEntity denotes ACE inhibitor
T15 686-707 DiseaseOrPhenotypicFeature denotes electrolyte imbalance
T16 804-816 DiseaseOrPhenotypicFeature denotes hyperkalemia
T17 855-862 ChemicalEntity denotes ACE/ARB
T18 883-907 ChemicalEntity denotes potassium sparing agents

biored-valid-gpt-r-g

Id Subject Object Predicate Lexical cue
T1 0-7 DiseaseOrPhenotypicFeature denotes Syncope
T2 18-30 DiseaseOrPhenotypicFeature denotes hyperkalemia
T3 73-112 ChemicalEntity denotes angiotensin-converting enzyme inhibitor
T4 117-131 ChemicalEntity denotes spironolactone
T5 213-234 DiseaseOrPhenotypicFeature denotes myocardial infarction
T6 278-299 DiseaseOrPhenotypicFeature denotes loss of consciousness
T7 314-325 DiseaseOrPhenotypicFeature denotes bradycardia
T8 336-348 DiseaseOrPhenotypicFeature denotes hyperkalemia
T9 377-386 ChemicalEntity denotes potassium
T10 464-473 ChemicalEntity denotes potassium
T11 494-506 DiseaseOrPhenotypicFeature denotes hyperkalemia
T12 545-559 ChemicalEntity denotes spiranolactone
T13 564-586 ChemicalEntity denotes aldosterone antagonist
T14 627-635 ChemicalEntity denotes ramipril
T15 640-653 ChemicalEntity denotes ACE inhibitor
T16 686-707 DiseaseOrPhenotypicFeature denotes electrolyte imbalance
T17 804-816 DiseaseOrPhenotypicFeature denotes hyperkalemia
T18 855-862 ChemicalEntity denotes ACE/ARB
T19 883-907 ChemicalEntity denotes potassium sparing agents
T20 926-943 DiseaseOrPhenotypicFeature denotes renal disturbance

biored-valid-gpt-r-ng

Id Subject Object Predicate Lexical cue
T1 0-7 DiseaseOrPhenotypicFeature denotes Syncope
T2 18-30 DiseaseOrPhenotypicFeature denotes hyperkalemia
T3 73-112 ChemicalEntity denotes angiotensin-converting enzyme inhibitor
T4 117-131 ChemicalEntity denotes spironolactone
T5 213-234 DiseaseOrPhenotypicFeature denotes myocardial infarction
T6 278-299 DiseaseOrPhenotypicFeature denotes loss of consciousness
T7 314-325 DiseaseOrPhenotypicFeature denotes bradycardia
T8 336-348 DiseaseOrPhenotypicFeature denotes hyperkalemia
T9 377-386 ChemicalEntity denotes potassium
T10 464-473 ChemicalEntity denotes potassium
T11 494-506 DiseaseOrPhenotypicFeature denotes hyperkalemia
T12 545-559 ChemicalEntity denotes spiranolactone
T13 564-586 ChemicalEntity denotes aldosterone antagonist
T14 627-635 ChemicalEntity denotes ramipril
T15 640-653 ChemicalEntity denotes ACE inhibitor
T16 686-707 DiseaseOrPhenotypicFeature denotes electrolyte imbalance
T17 804-816 DiseaseOrPhenotypicFeature denotes hyperkalemia
T18 855-862 ChemicalEntity denotes ACE/ARB
T19 883-907 ChemicalEntity denotes potassium sparing agents
T20 926-943 DiseaseOrPhenotypicFeature denotes renal disturbance

biored-valid-gemini-nr-g

Id Subject Object Predicate Lexical cue
T1 0-7 DiseaseOrPhenotypicFeature denotes Syncope
T2 18-30 DiseaseOrPhenotypicFeature denotes hyperkalemia
T3 73-112 ChemicalEntity denotes angiotensin-converting enzyme inhibitor
T4 117-131 ChemicalEntity denotes spironolactone
T5 171-202 DiseaseOrPhenotypicFeature denotes coronary artery bypass grafting
T6 213-234 DiseaseOrPhenotypicFeature denotes myocardial infarction
T7 278-299 DiseaseOrPhenotypicFeature denotes loss of consciousness
T8 307-325 DiseaseOrPhenotypicFeature denotes marked bradycardia
T9 336-348 DiseaseOrPhenotypicFeature denotes hyperkalemia
T10 377-386 ChemicalEntity denotes potassium
T11 464-473 ChemicalEntity denotes potassium
T12 494-506 DiseaseOrPhenotypicFeature denotes hyperkalemia
T13 545-559 ChemicalEntity denotes spiranolactone
T14 564-586 ChemicalEntity denotes aldosterone antagonist
T15 627-635 ChemicalEntity denotes ramipril
T16 640-653 ChemicalEntity denotes ACE inhibitor
T17 686-707 DiseaseOrPhenotypicFeature denotes electrolyte imbalance
T18 804-816 DiseaseOrPhenotypicFeature denotes hyperkalemia
T19 855-862 ChemicalEntity denotes ACE/ARB
T20 883-907 ChemicalEntity denotes potassium sparing agents
T21 921-943 DiseaseOrPhenotypicFeature denotes mild renal disturbance

biored-valid-gpt-r-m

Id Subject Object Predicate Lexical cue
T1 0-7 DiseaseOrPhenotypicFeature denotes Syncope
T2 18-30 DiseaseOrPhenotypicFeature denotes hyperkalemia
T3 73-112 ChemicalEntity denotes angiotensin-converting enzyme inhibitor
T4 117-131 ChemicalEntity denotes spironolactone
T5 213-234 DiseaseOrPhenotypicFeature denotes myocardial infarction
T6 278-299 DiseaseOrPhenotypicFeature denotes loss of consciousness
T7 314-325 DiseaseOrPhenotypicFeature denotes bradycardia
T8 336-348 DiseaseOrPhenotypicFeature denotes hyperkalemia
T9 377-386 ChemicalEntity denotes potassium
T10 464-473 ChemicalEntity denotes potassium
T11 494-506 DiseaseOrPhenotypicFeature denotes hyperkalemia
T12 545-559 ChemicalEntity denotes spiranolactone
T13 564-586 ChemicalEntity denotes aldosterone antagonist
T14 627-635 ChemicalEntity denotes ramipril
T15 640-653 ChemicalEntity denotes ACE inhibitor
T16 686-707 DiseaseOrPhenotypicFeature denotes electrolyte imbalance
T17 804-816 DiseaseOrPhenotypicFeature denotes hyperkalemia
T18 840-848 OrganismTaxon denotes patients
T19 855-862 ChemicalEntity denotes ACE/ARB
T20 883-907 ChemicalEntity denotes potassium sparing agents

biored-valid-gemini-r-m

Id Subject Object Predicate Lexical cue
T1 0-7 DiseaseOrPhenotypicFeature denotes Syncope
T2 18-30 DiseaseOrPhenotypicFeature denotes hyperkalemia
T3 73-102 GeneOrGeneProduct denotes angiotensin-converting enzyme
T4 117-131 ChemicalEntity denotes spironolactone
T5 147-152 OrganismTaxon denotes woman
T6 213-234 DiseaseOrPhenotypicFeature denotes myocardial infarction
T7 278-299 DiseaseOrPhenotypicFeature denotes loss of consciousness
T8 314-325 DiseaseOrPhenotypicFeature denotes bradycardia
T9 336-348 DiseaseOrPhenotypicFeature denotes hyperkalemia
T10 377-386 ChemicalEntity denotes potassium
T11 494-506 DiseaseOrPhenotypicFeature denotes hyperkalemia
T12 545-559 ChemicalEntity denotes spiranolactone
T13 564-575 ChemicalEntity denotes aldosterone
T14 627-635 ChemicalEntity denotes ramipril
T15 640-643 GeneOrGeneProduct denotes ACE
T16 686-707 DiseaseOrPhenotypicFeature denotes electrolyte imbalance
T17 739-753 DiseaseOrPhenotypicFeature denotes cardiac events
T18 804-816 DiseaseOrPhenotypicFeature denotes hyperkalemia
T19 840-848 OrganismTaxon denotes patients
T20 855-858 GeneOrGeneProduct denotes ACE
T21 859-862 ChemicalEntity denotes ARB
T22 883-892 ChemicalEntity denotes potassium
T23 926-943 DiseaseOrPhenotypicFeature denotes renal disturbance

biored-valid-deepseek-r-m

Id Subject Object Predicate Lexical cue
T1 0-7 DiseaseOrPhenotypicFeature denotes Syncope
T2 18-30 DiseaseOrPhenotypicFeature denotes hyperkalemia
T3 73-112 ChemicalEntity denotes angiotensin-converting enzyme inhibitor
T4 117-131 ChemicalEntity denotes spironolactone
T5 213-234 DiseaseOrPhenotypicFeature denotes myocardial infarction
T6 278-299 DiseaseOrPhenotypicFeature denotes loss of consciousness
T7 314-325 DiseaseOrPhenotypicFeature denotes bradycardia
T8 336-348 DiseaseOrPhenotypicFeature denotes hyperkalemia
T9 377-386 ChemicalEntity denotes potassium
T10 494-506 DiseaseOrPhenotypicFeature denotes hyperkalemia
T11 545-559 ChemicalEntity denotes spiranolactone
T12 564-586 ChemicalEntity denotes aldosterone antagonist
T13 627-635 ChemicalEntity denotes ramipril
T14 640-653 ChemicalEntity denotes ACE inhibitor
T15 686-707 DiseaseOrPhenotypicFeature denotes electrolyte imbalance
T16 855-862 ChemicalEntity denotes ACE/ARB
T17 883-907 ChemicalEntity denotes potassium sparing agents
T18 921-943 DiseaseOrPhenotypicFeature denotes mild renal disturbance